tetano
Editor, Senior Moderator
Vaccines (Basel)
. 2022 Dec 17;10(12):2172.
doi: 10.3390/vaccines10122172.
COVID-19: Impact of Original, Gamma, Delta, and Omicron Variants of SARS-CoV-2 in Vaccinated and Unvaccinated Pregnant and Postpartum Women
Fabiano Elisei Serra[SUP] 1 2 3 [/SUP], Elias Ribeiro Rosa Junior[SUP] 4 [/SUP], Patricia de Rossi[SUP] 2 5 [/SUP], Rossana Pulcineli Vieira Francisco[SUP] 1 [/SUP], Agatha Sacramento Rodrigues[SUP] 1 4 [/SUP]
Affiliations
Abstract
This study compares the clinical characteristics and disease progression among vaccinated and unvaccinated pregnant and postpartum women who tested positive for different variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using the Brazilian epidemiological data. Data of pregnant or postpartum patients testing positive for SARS-CoV-2 and presenting with coronavirus disease 2019 (COVID-19) from February 2020 to July 2022 were extracted from Brazilian national database. The patients were grouped based on vaccination status and viral variant (original, Gamma, Delta, and Omicron variants), and their demographics, clinical characteristics, comorbidities, symptoms, and outcomes were compared retrospectively. Data of 10,003 pregnant and 2361 postpartum women were extracted from the database. For unvaccinated postpartum women, intensive care unit (ICU) admission was more likely; invasive ventilation need was more probable if they tested positive for the original, Gamma, and Omicron variants; and chances of death were higher when infected with the original and Gamma variants than when infected with other variants. Vaccinated patients had reduced adverse outcome probability, including ICU admission, invasive ventilation requirement, and death. Postpartum women showed worse outcomes, particularly when unvaccinated, than pregnant women. Hence, vaccination of pregnant and postpartum women should be given top priority.
Keywords: COVID-19; SARS-CoV-2; obstetric population; obstetrics; postpartum period; pregnancy; puerperal period; vaccines; variants of concern.
. 2022 Dec 17;10(12):2172.
doi: 10.3390/vaccines10122172.
COVID-19: Impact of Original, Gamma, Delta, and Omicron Variants of SARS-CoV-2 in Vaccinated and Unvaccinated Pregnant and Postpartum Women
Fabiano Elisei Serra[SUP] 1 2 3 [/SUP], Elias Ribeiro Rosa Junior[SUP] 4 [/SUP], Patricia de Rossi[SUP] 2 5 [/SUP], Rossana Pulcineli Vieira Francisco[SUP] 1 [/SUP], Agatha Sacramento Rodrigues[SUP] 1 4 [/SUP]
Affiliations
- PMID: 36560582
- DOI: 10.3390/vaccines10122172
Abstract
This study compares the clinical characteristics and disease progression among vaccinated and unvaccinated pregnant and postpartum women who tested positive for different variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using the Brazilian epidemiological data. Data of pregnant or postpartum patients testing positive for SARS-CoV-2 and presenting with coronavirus disease 2019 (COVID-19) from February 2020 to July 2022 were extracted from Brazilian national database. The patients were grouped based on vaccination status and viral variant (original, Gamma, Delta, and Omicron variants), and their demographics, clinical characteristics, comorbidities, symptoms, and outcomes were compared retrospectively. Data of 10,003 pregnant and 2361 postpartum women were extracted from the database. For unvaccinated postpartum women, intensive care unit (ICU) admission was more likely; invasive ventilation need was more probable if they tested positive for the original, Gamma, and Omicron variants; and chances of death were higher when infected with the original and Gamma variants than when infected with other variants. Vaccinated patients had reduced adverse outcome probability, including ICU admission, invasive ventilation requirement, and death. Postpartum women showed worse outcomes, particularly when unvaccinated, than pregnant women. Hence, vaccination of pregnant and postpartum women should be given top priority.
Keywords: COVID-19; SARS-CoV-2; obstetric population; obstetrics; postpartum period; pregnancy; puerperal period; vaccines; variants of concern.